TBCH shareholder plans sale of 2,500 common shares

TBCH shareholder Andrew Wolfe has filed a notice of proposed sale of common stock.

Rhea-AI Filing Summary

TBCH shareholder Andrew Wolfe has filed a notice of proposed sale of common stock. The notice covers 2,500 shares of common stock to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on July 20, 2026, with an aggregate value of $32,525.00 and listing on NASDAQ. Wolfe also reports prior sales during the past three months, including 2,500 shares for $32,700.00 on June 16, 2026, 11,076 shares for $142,277.87 on June 9, 2026, and 5,193 shares for $67,606.11 on June 3, 2026. The 2,500 shares covered by the proposed sale are noted as restricted stock acquired from the issuer on April 11, 2019.

Key Figures

Planned shares to be sold: 2,500 shares Planned aggregate sale value: $32,525.00 Sale on June 16, 2026: 2,500 shares for $32,700.00 +4 more

7 metrics

Planned shares to be sold 2,500 shares Common stock proposed for sale on July 20, 2026

Planned aggregate sale value $32,525.00 Value for 2,500 TBCH common shares in proposed July 20, 2026 sale

Sale on June 16, 2026 2,500 shares for $32,700.00 TBCH common stock sold by Andrew Wolfe

Sale on June 9, 2026 11,076 shares for $142,277.87 TBCH common stock sold during past three months

Sale on June 3, 2026 5,193 shares for $67,606.11 TBCH common stock sold during past three months

Acquisition date of restricted stock April 11, 2019 Date 2,500 restricted shares were acquired from issuer

Trading market NASDAQ Listing market for TBCH common stock in proposed sale

Key Terms

restricted stock, aggregate value, common stock, securities sold during the past 3 months

4 terms

restricted stock financial

"Common | 04/11/2019 | Restricted Stock | ISSUER"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

aggregate value financial

"Common | Morgan Stanley Smith Barney LLC... | 2500 | 32525.00"

common stock financial

"Common | 06/16/2026 | 2500 | 32700.00"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

securities sold during the past 3 months regulatory

"144: Securities Sold During The Past 3 Months"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is Andrew Wolfe planning for TBCH?

Andrew Wolfe plans a proposed sale of 2,500 shares of TBCH common stock through Morgan Stanley Smith Barney on July 20, 2026, with an aggregate value of $32,525.00 listed on NASDAQ.

What TBCH shares did Andrew Wolfe sell in the past three months?

Andrew Wolfe reports three TBCH common stock sales: 2,500 shares for $32,700.00 on June 16, 2026; 11,076 shares for $142,277.87 on June 9, 2026; and 5,193 shares for $67,606.11 on June 3, 2026.

What type of TBCH securities are covered by Andrew Wolfe’s planned sale?

The proposed transaction covers 2,500 shares of TBCH common stock identified as restricted stock, originally acquired from the issuer on April 11, 2019 and now noticed for potential sale.

Through which broker will Andrew Wolfe’s TBCH shares be sold?

The proposed sale of 2,500 TBCH common shares is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, 8th Floor, New York, NY 10004.

On which market are Andrew Wolfe’s TBCH shares listed?

The 2,500 shares of TBCH common stock covered by the proposed sale are listed on the NASDAQ market, with an indicated aggregate value of $32,525.00 for the planned transaction.

When did Andrew Wolfe acquire the TBCH restricted stock he plans to sell?

The 2,500 restricted TBCH shares covered by the proposed sale were acquired from the issuer on April 11, 2019, later noticed for potential sale as common stock on July 20, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/20/2026 - 04:04 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001542884
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TURTLE BEACH CORPORATION
SEC File Number	001-35465
Address of Issuer	15822 Bernardo Center Drive, Suite 105 San Diego CALIFORNIA 92127
Phone	(914) 345-2255
Name of Person for Whose Account the Securities are To Be Sold	ANDREW WOLFE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2500	32525.00	19847421	07/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/11/2019	Restricted Stock	ISSUER			2500	04/11/2019	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ANDREW WOLFE 15822 Bernardo Center Drive, Suite 105 San Diego CA 92127	Common	06/16/2026	2500	32700.00
ANDREW WOLFE 15822 Bernardo Center Drive, Suite 105 San Diego CA 92127	Common	06/09/2026	11076	142277.87
ANDREW WOLFE 15822 Bernardo Center Drive, Suite 105 San Diego CA 92127	Common	06/03/2026	5193	67606.11

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of Restricted Stock during the period of 04/01/2019 through 04/01/2022.
Date of Notice	07/20/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Andrew Wolfe
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)